Pediatric and Adult Congenital Cardiac Surgery Unit, S.Orsola-Malpighi Hospital, University of Bologna Medical School, Bologna, Italy.
Eur J Cardiothorac Surg. 2010 Mar;37(3):645-50. doi: 10.1016/j.ejcts.2009.09.003. Epub 2009 Oct 2.
The modified Fontan procedure represents the final stage for the palliation of hearts with single-ventricle physiology. Different opinions exist regarding the optimal timing of the operation, with most centres advocating early intervention. By contrast, over the past decade, we have progressively increased the age at Fontan operation with the aim to potentially delay the onset of late Fontan failure, and to possibly use larger extracardiac conduits. We retrospectively reviewed our surgical experience with Fontan operation, to understand the impact of this strategy on morbidity and mortality.
Between 1990 and 2008, 65 patients underwent a modified Fontan operation at our institution (extracardiac conduit in 52 and lateral tunnel in 13). The median age at operation in our series was 7.3 years (range: 2.2-15.8 years) and this value was used to divide the study cohort into two groups. Group A (n=28) included patients with an age at Fontan operation <or=7 years, whereas group B (n=37) included patients who had a Fontan operation at >7 years of age. Preoperative characteristics, intra-operative data and short- and medium-term results were assessed.
No differences in baseline characteristics, morbidity and mortality were evident between groups. Hospital mortality was 0% in group A and 5.4% (2/37) in group B (p=0.5). Prolonged pleural effusions were present in eight patients in group A (29%) and seven in group B (19%, p=0.39). After a mean follow-up of 5.7+/-5.4 years (range: 0.3-18 years), the overall mortality of group A (1/28) was similar to that of group B (2/37) (3.6% vs 5.4%, p=0.999). The incidence of arrhythmias, protein-losing enteropathy, Fontan take down and re-operation were not different between the two groups.
The modified Fontan operation can be performed safely in older patients without affecting operative and medium-term follow-up results. Postponing the extracardiac Fontan operation may have the advantage of the use of a larger conduit.
改良 Fontan 手术代表了单心室生理心脏姑息治疗的最后阶段。对于手术的最佳时机存在不同意见,大多数中心主张早期干预。相比之下,在过去的十年中,我们逐渐提高了 Fontan 手术的年龄,旨在潜在地延迟晚期 Fontan 衰竭的发生,并可能使用更大的体外循环导管。我们回顾性地分析了我们的 Fontan 手术经验,以了解该策略对发病率和死亡率的影响。
1990 年至 2008 年间,我们机构有 65 例患者接受了改良 Fontan 手术(52 例采用体外循环导管,13 例采用侧隧道)。本系列中位手术年龄为 7.3 岁(范围:2.2-15.8 岁),并以此值将研究队列分为两组。A 组(n=28)包括 Fontan 手术年龄≤7 岁的患者,而 B 组(n=37)包括 Fontan 手术年龄>7 岁的患者。评估了术前特征、术中数据以及短期和中期结果。
两组在基线特征、发病率和死亡率方面均无差异。A 组的院内死亡率为 0%(28 例中无死亡),B 组为 5.4%(37 例中有 2 例死亡)(p=0.5)。A 组中有 8 例(29%)和 B 组中有 7 例(19%)患者存在持续性胸腔积液(p=0.39)。平均随访 5.7+/-5.4 年后(范围:0.3-18 年),A 组的总死亡率(1/28)与 B 组(2/37)相似(3.6%比 5.4%,p=0.999)。两组心律失常、蛋白丢失性肠病、Fontan 关闭和再次手术的发生率无差异。
改良 Fontan 手术可安全应用于老年患者,而不会影响手术和中期随访结果。延迟体外循环 Fontan 手术可能具有使用更大导管的优势。